KANE BIOTECH INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.125 CAD | -3.85% |
|
-7.41% | +56.25% |
| Apr. 18 | Transcript : Kane Biotech Inc. - Special Call | |
| Apr. 15 | Kane Biotech Up 12% After Reporting Closing of STEM Animal Health Sale | MT |
Presenter SpeechPhilip Renaud (Executives)Hello. This is Philip Renaud. The notice of this mee...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. It has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its Wound Care & Surgical division is focused on the product development of DispersinB for applications in chronic wound care. Its bluestem product line includes water additives, chews, spray and dental wipes. Its other products in development stage include Coactiv+, antimicrobial wound rinse for use in acute and chronic wounds; Coactiv+, antimicrobial surgical hydrogel for use in surgical and acute wounds, and DispersinB Gel for prosthetic joint infection. It also provides Scalp Detoxifier, Shampoo and Shampoo Bars. Its primary markets for its technologies are animal health and human health.
Calendar
2024-05-21
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| +56.25% | 12.04M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- KNE Stock
- News Kane Biotech Inc.
- Transcript : Kane Biotech Inc. - Shareholder/Analyst Call
